{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:53:50Z","timestamp":1790420030600,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019125","name":"National Institute of Pharmaceutical Education and Research, Ahmedabad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019125","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014824","name":"Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014824","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials Advances"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bioadv.2025.214542","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:57:23Z","timestamp":1759798643000},"page":"214542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["PEGylated liposomes co-encapsulating darolutamide and hesperetin for enhanced prostate cancer therapy: 2D, 3D PC3 models and in-vivo evaluation"],"prefix":"10.1016","volume":"180","author":[{"given":"Ruchita","family":"Patil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekta","family":"Pardhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Khemchandani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avinash","family":"Pawar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gananadhamu","family":"Smanthula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neelesh Kumar","family":"Mehra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioadv.2025.214542_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.125056","article-title":"Multi-method coamorphous systems of lumefantrine with alpha ketoglutaric acid: Comprehensive characterization, biological evaluation and stability analysis","volume":"669","author":"Khemchandani","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2025.214542_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119556","article-title":"Molecular insights and novel approaches for targeting tumor metastasis","volume":"585","author":"Das","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2025.214542_bb0015","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bioadv.2025.214542_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2217\/nnm-2024-0013","article-title":"Tailoring micellar nanocarriers for pemetrexed in breast cancer: design, fabrication and in vitro evaluation","author":"Kumari","year":"2024","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bioadv.2025.214542_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.sintl.2020.100077","article-title":"Design and release kinetics of liposomes containing abiraterone acetate for treatment of prostate cancer","volume":"2","author":"Das","year":"2021","journal-title":"Sensors International"},{"key":"10.1016\/j.bioadv.2025.214542_bb0030","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.euo.2021.09.006","article-title":"Epidemiology and Prevention of Prostate Cancer","volume":"4","author":"Gandaglia","year":"2021","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.bioadv.2025.214542_bb0035","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.eururo.2011.08.026","article-title":"Contemporary Role of Androgen Deprivation Therapy for Prostate Cancer","volume":"61","author":"Pagliarulo","year":"2012","journal-title":"Eur. Urol."},{"key":"10.1016\/j.bioadv.2025.214542_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.00801","article-title":"Second-Generation Antiandrogens: From Discovery to Standard of Care in Castration Resistant Prostate Cancer","volume":"9","author":"Rice","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bioadv.2025.214542_bb0045","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.clgc.2018.07.017","article-title":"Clinical Development of Darolutamide: A Novel Androgen Receptor Antagonist for the Treatment of Prostate Cancer","volume":"16","author":"Fizazi","year":"2018","journal-title":"Clin. Genitourin. Cancer"},{"key":"10.1016\/j.bioadv.2025.214542_bb0050","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1007\/s40265-019-01212-y","article-title":"Darolutamide: First Approval","volume":"79","author":"Markham","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.bioadv.2025.214542_bb0055","unstructured":"DailyMed - NUBEQA- darolutamide tablet, film coated, (n.d.). https:\/\/dailymed-beta.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=1a7cb212-56e4-4b9d-a73d-bfee7fe4735e&audience=consumer (accessed May 8, 2025)."},{"key":"10.1016\/j.bioadv.2025.214542_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121771","article-title":"Multifunctional targetable liposomal drug delivery system in the management of leukemia: Potential, opportunities, and emerging strategies","volume":"325","author":"Pardhi","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.bioadv.2025.214542_bb0065","article-title":"An apprise on novel drug delivery systems for management of diabetes mellitus","volume":"94","author":"Pardhi","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.bioadv.2025.214542_bb0070","article-title":"A review on Stimuli-pH responsive liposomal formulation in cancer therapy","volume":"90","author":"Jayapriya","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.bioadv.2025.214542_bb0075","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejpb.2015.03.018","article-title":"Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy","volume":"93","author":"P\u00e9rez-Herrero","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bioadv.2025.214542_bb0080","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4155\/tde-2023-0092","article-title":"Exploring Contemporary Breakthroughs in Utilizing Vesicular Nanocarriers for Breast Cancer Therapy","volume":"15","author":"Kumari","year":"2024","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.bioadv.2025.214542_bb0085","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.biopha.2018.09.128","article-title":"A novel 5-Fluorouracil targeted delivery to colon cancer using folic acid conjugated liposomes","volume":"108","author":"Handali","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bioadv.2025.214542_bb0090","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.biomaterials.2015.10.027","article-title":"Doxorubicin encapsulated in stealth liposomes conferred with light-triggered drug release","volume":"75","author":"Luo","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioadv.2025.214542_bb0095","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.963317","article-title":"Synergistic effects of natural products in combination with anticancer agents in prostate cancer: A scoping review","volume":"13","author":"Cheon","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioadv.2025.214542_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122295","article-title":"Protective role of hesperetin in sorafenib-induced hepato- and neurotoxicity in mice via modulating apoptotic pathways and mitochondrial reprogramming","volume":"336","author":"Zaafar","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.bioadv.2025.214542_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.adcanc.2022.100077","article-title":"Hesperetin modulates TGF\u03b2 induced metastatic potential of prostate cancer cells by altering histone methylation marks","volume":"6","author":"Dalpatraj","year":"2022","journal-title":"Advances in Cancer Biology - Metastasis"},{"key":"10.1016\/j.bioadv.2025.214542_bb0110","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ijpharm.2008.12.030","article-title":"Production and characterization of Hesperetin nanosuspensions for dermal delivery","volume":"371","author":"Mishra","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2025.214542_bb0115","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1021\/mp5008647","article-title":"Oral Bioavailability and Pharmacodynamic Activity of Hesperetin Nanocrystals Generated Using a Novel Bottom-up Technology","volume":"12","author":"Shete","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bioadv.2025.214542_bb0120","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drudis.2019.09.017","article-title":"Clinical applications of nanomedicine in cancer therapy","volume":"25","author":"Norouzi","year":"2020","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioadv.2025.214542_bb0125","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.colsurfb.2018.08.022","article-title":"PEGylated liposomes as delivery systems for Gambogenic acid: Characterization and in vitro\/in vivo evaluation","volume":"172","author":"Tang","year":"2018","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.bioadv.2025.214542_bb0130","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/pharmaceutics8040036","article-title":"Evaluation of Extrusion Technique for Nanosizing Liposomes","volume":"8","author":"Ong","year":"2016","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioadv.2025.214542_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2025.127225","article-title":"Enhancing solubility, bioavailability and anti-cancer efficacy of aprepitant through a naringin-based co-amorphous system","volume":"425","author":"Pardhi","year":"2025","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.bioadv.2025.214542_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.137045","article-title":"Design, development and characterization of the Apremilast and Indomethacin coamorphous system","volume":"1299","author":"Pardhi","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioadv.2025.214542_bb0145","unstructured":"ICH Official web site\u00a0: ICH. https:\/\/www.ich.org\/page\/quality-guidelines - Google Search, (n.d.). https:\/\/www.google.com\/search?q=ICH+Official+web+site+%3A+ICH.+https%3A%2F%2Fwww.ich.org%2Fpage%2Fquality-guidelines&oq=ICH+Official+web+site%E2%80%AF%3A+ICH.+https%3A%2F%2Fwww.ich.org%2Fpage%2Fquality-guidelines&gs_lcrp=EgZjaHJvbWUyBggAEEUYOdIBCTE0OTlqMGoxNagCCLACAfEFeJ_vfHhWhTw&sourceid=chrome&ie=UTF-8 (accessed September 23, 2025)."},{"key":"10.1016\/j.bioadv.2025.214542_bb0150","article-title":"Preparation and evaluation of gemcitabin and cisplatin-entrapped Folate-PEGylated liposomes as targeting co-drug delivery system in cancer therapy","volume":"65","author":"Pakdaman Goli","year":"2021","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.bioadv.2025.214542_bb0155","doi-asserted-by":"crossref","DOI":"10.1590\/0103-644020246054","article-title":"Dimethyl sulfoxide affects the viability and mineralization activity of apical papilla cells in vitro","volume":"35","author":"Santos","year":"2024","journal-title":"Braz. Dent. J."},{"key":"10.1016\/j.bioadv.2025.214542_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemphyslip.2018.11.009","article-title":"Cabazitaxel and thymoquinone co-loaded lipospheres as a synergistic combination for breast cancer","volume":"224","author":"Kommineni","year":"2019","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.bioadv.2025.214542_bb0165","first-page":"1","article-title":"Solid supersaturated self-nanoemulsifying drug delivery system for abiraterone acetate: improved drug loading, dissolution, cellular uptake, and anticancer activity","author":"Nair","year":"2025","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.bioadv.2025.214542_bb0170","doi-asserted-by":"crossref","first-page":"34360","DOI":"10.1021\/acsami.3c03233","article-title":"Co-Delivery of Hesperetin and Cisplatin via Hyaluronic Acid-Modified Liposome for Targeted Inhibition of Aggression and Metastasis of Triple-Negative Breast Cancer","volume":"15","author":"Wang","year":"2023","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.bioadv.2025.214542_bb0175","article-title":"Enhanced bioavailability and therapeutic efficacy of Ibrutinib and naringenin-loaded self-nanoemulsifying drug delivery system","volume":"109","author":"Jati","year":"2025","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.bioadv.2025.214542_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.142185","article-title":"Development and evaluation of nilotinib-loaded Bovine Serum Albumin nanoparticles: In-vitro and in-silico insights","volume":"308","author":"Shaikh","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioadv.2025.214542_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.140316","article-title":"Fabrication and characterization of teriflunomide-loaded chondroitin sulfate hybridized zein nanoparticles for the management of triple negative breast cancer","volume":"300","author":"Rajana","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioadv.2025.214542_bb0190","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.2147\/IJN.S362263","article-title":"Estrone-Conjugated PEGylated Liposome Co-Loaded Paclitaxel and Carboplatin Improve Anti-Tumor Efficacy in Ovarian Cancer and Reduce Acute Toxicity of Chemo-Drugs","volume":"17","author":"Tang","year":"2022","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.bioadv.2025.214542_bb0195","doi-asserted-by":"crossref","first-page":"242","DOI":"10.5599\/admet.557","article-title":"Development and validation of a novel method for simultaneous quantification of enzalutamide, darolutamide and their active metabolites in mice dried blood spots using LC-MS\/MS: Application to pharmacokinetic study in mice","volume":"6","author":"Saini","year":"2018","journal-title":"ADMET DMPK"},{"key":"10.1016\/j.bioadv.2025.214542_bb0200","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ijpharm.2018.06.037","article-title":"Practical aspects in size and morphology characterization of drug-loaded nano-liposomes","volume":"547","author":"Peretz Damari","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2025.214542_bb0205","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1208\/s12249-017-0831-0","article-title":"Enhanced Ungual Permeation of Terbinafine HCl Delivered Through Liposome-Loaded Nail Lacquer Formulation Optimized by QbD Approach","volume":"19","author":"Shah","year":"2018","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.bioadv.2025.214542_bb0210","doi-asserted-by":"crossref","DOI":"10.1063\/1.4962992","article-title":"Physical characterization of nanoparticle size and surface modification using particle scattering diffusometry","volume":"10","author":"Clayton","year":"2016","journal-title":"Biomicrofluidics"},{"key":"10.1016\/j.bioadv.2025.214542_bb0215","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1038\/s41598-025-85463-8","article-title":"QbD-Driven preparation, characterization, and pharmacokinetic investigation of daidzein-l oaded nano-cargos of hydroxyapatite","volume":"15","author":"Gautam","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioadv.2025.214542_bb0220","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1021\/mp400366r","article-title":"The Combined Effect of Encapsulating Curcumin and C6 Ceramide in Liposomal Nanoparticles against Osteosarcoma","volume":"11","author":"Dhule","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bioadv.2025.214542_bb0225","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.nano.2010.01.002","article-title":"Enhanced transdermal delivery of an anti-HIV agent via ethanolic liposomes","volume":"6","author":"Dubey","year":"2010","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bioadv.2025.214542_bb0230","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.2147\/DDDT.S129008","article-title":"Development of antiproliferative long-circulating liposomes co-encapsulating doxorubicin and curcumin, through the use of a quality-by-design approach","volume":"11","author":"Tefas","year":"2017","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.bioadv.2025.214542_bb0235","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.jff.2013.05.006","article-title":"Novel hesperetin loaded nanocarriers for food fortification: Production and characterization","volume":"5","author":"Fathi","year":"2013","journal-title":"J. Funct. Foods"},{"key":"10.1016\/j.bioadv.2025.214542_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfa.2022.128935","article-title":"Folic acid-modified curcumin-loaded liposomes for breast cancer therapy","volume":"645","author":"Luiz","year":"2022","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"key":"10.1016\/j.bioadv.2025.214542_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfa.2023.131773","article-title":"Co-delivery of berberine and magnolol targeted liposomes for synergistic anti-lung cancer","volume":"673","author":"Ma","year":"2023","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"10.1016\/j.bioadv.2025.214542_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.nanoso.2019.100288","article-title":"Synthesis and characterization of celecoxib loaded PEGylated liposome nanoparticles for biomedical applications","volume":"18","author":"Dave","year":"2019","journal-title":"Nano-Structures & Nano-Objects"},{"key":"10.1016\/j.bioadv.2025.214542_bb0255","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s13204-015-0408-8","article-title":"Factorial design studies of antiretroviral drug-loaded stealth liposomal injectable: PEGylation, lyophilization and pharmacokinetic studies","volume":"6","author":"Sudhakar","year":"2016","journal-title":"Appl. Nanosci."},{"key":"10.1016\/j.bioadv.2025.214542_bb0260","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics10020057","article-title":"Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems","volume":"10","author":"Danaei","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioadv.2025.214542_bb0265","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.66669","article-title":"PEGylation in Pharmaceutical Development: Current Status and Emerging Trends in Macromolecular and Immunotherapeutic Drugs","author":"Santhanakrishnan","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.bioadv.2025.214542_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.130060","article-title":"Investigation of cellular uptake and transport capacity of Cordyceps sinensis exopolysaccharide-selenium nanoparticles with different particle sizes in Caco-2 cell monolayer","volume":"262","author":"Zhang","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioadv.2025.214542_bb0275","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ijpharm.2019.06.026","article-title":"Functionalized liposomal nanoparticles for efficient gene delivery system to neuronal cell transfection","volume":"566","author":"dos Santos Rodrigues","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioadv.2025.214542_bb0280","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1021\/acsptsci.4c00419","article-title":"PEGylation-Dependent Cell Uptake of Lipid Nanoparticles Revealed by Spatiotemporal Correlation Spectroscopy","volume":"7","author":"Digiacomo","year":"2024","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1016\/j.bioadv.2025.214542_bb0285","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.3390\/ijms22094642","article-title":"The Chemistry of Reactive Oxygen Species (ROS) Revisited: Outlining Their Role in Biological Macromolecules (DNA, Lipids and Proteins) and Induced Pathologies","volume":"22","author":"Juan","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioadv.2025.214542_bb0290","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.vascn.2018.03.007","article-title":"Real time monitoring and quantification of reactive oxygen species in breast cancer cell line MCF-7 by 2\u2032,7\u2032\u2013dichlorofluorescin diacetate (DCFDA) assay","volume":"94","author":"Figueroa","year":"2018","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.bioadv.2025.214542_bb0295","series-title":"Labeling Nuclear DNA Using DAPI, Cold Spring Harb Protoc 2011","author":"Chazotte","year":"2011"},{"key":"10.1016\/j.bioadv.2025.214542_bb0300","doi-asserted-by":"crossref","DOI":"10.3791\/2573","article-title":"Clonogenic Assay: Adherent Cells","author":"Rafehi","year":"2011","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.bioadv.2025.214542_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116332","article-title":"P53: A key player in diverse cellular processes including nuclear stress and ribosome biogenesis, highlighting potential therapeutic compounds","volume":"226","author":"Temaj","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioadv.2025.214542_bb0310","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2147\/IJN.S228715","article-title":"Preparation, characterization, and pharmacokinetic study of a novel long-acting targeted paclitaxel liposome with antitumor activity","volume":"15","author":"Han","year":"2020","journal-title":"Int. J. Nanomedicine"}],"container-title":["Biomaterials Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950825003693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772950825003693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T16:51:58Z","timestamp":1765212718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772950825003693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":62,"alternative-id":["S2772950825003693"],"URL":"https:\/\/doi.org\/10.1016\/j.bioadv.2025.214542","relation":{},"ISSN":["2772-9508"],"issn-type":[{"value":"2772-9508","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PEGylated liposomes co-encapsulating darolutamide and hesperetin for enhanced prostate cancer therapy: 2D, 3D PC3 models and in-vivo evaluation","name":"articletitle","label":"Article Title"},{"value":"Biomaterials Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioadv.2025.214542","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"214542"}}